Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |